Elevation Oncology Files Q1 2025 10-Q
| Field | Detail |
|---|---|
| Company | Elevation Oncology, Inc. |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, warrants, biotech
TL;DR
Elevation Oncology's Q1 2025 10-Q is in, showing warrant details and financial updates.
AI Summary
Elevation Oncology, Inc. filed its quarterly report for the period ending March 31, 2025. The filing details financial information and business operations, including references to warrants and their valuation inputs such as share price, risk-free interest rate, price volatility, expected term, and exercise price as of March 31, 2025. The company was formerly known as 14ner Oncology, Inc. and changed its name on July 19, 2019.
Why It Matters
This filing provides investors with an update on Elevation Oncology's financial health and operational status for the first quarter of 2025, crucial for investment decisions.
Risk Assessment
Risk Level: medium — Biotech companies like Elevation Oncology often face inherent risks related to drug development, clinical trials, and regulatory approvals, which can significantly impact their financial performance.
Key Numbers
- N/A — Revenue (Specific revenue figures are not detailed in the provided snippet.)
- N/A — Net Income (Specific net income figures are not detailed in the provided snippet.)
- N/A — Cash Flow (Specific cash flow figures are not detailed in the provided snippet.)
Key Players & Entities
- Elevation Oncology, Inc. (company) — Filer
- March 31, 2025 (date) — Reporting period end date
- 14ner Oncology, Inc. (company) — Former company name
- July 19, 2019 (date) — Date of former company name change
- 0001783032 (company) — Central Index Key
FAQ
What are the key valuation inputs for Elevation Oncology's warrants as of March 31, 2025?
As of March 31, 2025, the key valuation inputs for Elevation Oncology's warrants include share price, risk-free interest rate, price volatility, expected term, and exercise price.
What was Elevation Oncology's former company name?
Elevation Oncology, Inc. was formerly known as 14ner Oncology, Inc.
When did the company change its name from 14ner Oncology, Inc.?
The company changed its name from 14ner Oncology, Inc. on July 19, 2019.
What is the reporting period for this 10-Q filing?
This 10-Q filing is for the period ending March 31, 2025.
What is the Standard Industrial Classification (SIC) code for Elevation Oncology, Inc.?
The Standard Industrial Classification (SIC) code for Elevation Oncology, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding Elevation Oncology, Inc..